IVF Success Rate Data and Influencing Factors for Women Under 35

Opening: Real Consultation Scenario

▎Clinic Scenario
A 32-year-old woman holding her AMH report asks: "Doctor, I'm so young, my chances of IVF success are very high, right? I saw online that it's over 60% for women under 35, is that true?" — This is one of the most common questions heard in the reproductive clinic. Youth is indeed a positive indicator, but the success rate is never a fixed number.

1. IVF Success Rate Under 35: Clinical Data Range

According to annual quality control reports from multiple domestic reproductive centers, the clinical pregnancy rate (gestational sac visible on ultrasound) for a single fresh embryo transfer in women under 35 is concentrated between 50%‑65%, and the live birth rate (delivery of a live infant) is approximately 45%‑55%. The pregnancy rate for frozen-thawed embryo transfer (FET) is generally comparable to or slightly higher than fresh embryo transfer, with some centers reporting rates of 55%‑68%.

These data are derived from publicly available annual reports on assisted reproductive technology published between 2020 and 2023 (e.g., quality control data from the Chinese Journal of Reproduction and Contraception), covering more than 30 provincial-level reproductive centers in China. It should be noted that due to differences in patient selection criteria, laboratory standards, and transfer strategies among different reproductive centers, the data fluctuates by approximately ±8%.

2. Why Do Individual Differences in IVF Success Rates Exist Among Young Women?

Many young patients mistakenly believe that "being young guarantees success on the first try," overlooking the following core variables:

• Ovarian Reserve Function: AMH and antral follicle count (AFC) determine the number of oocytes retrieved. Among women under 35, approximately 8%‑12% still have diminished ovarian reserve (AMH < 1.1 ng/mL), and the success rate drops significantly when the number of retrieved oocytes is ≤5.
• Embryonic Chromosomal Normalcy Rate: Although the aneuploidy rate is lower in women under 35, approximately 20%‑30% of embryos still have chromosomal abnormalities, which are related to sperm quality and oocyte maturity.
• Uterine Environment: Endometrial thickness < 7 mm, intrauterine adhesions, chronic endometritis, and uterine fibroids (submucosal type) can all reduce the implantation rate.
• Transfer Strategy: Single blastocyst transfer vs. double cleavage-stage embryo transfer, fresh vs. frozen embryo transfer, and whether to perform PGT-A are choices that directly affect the success rate of a single transfer.

3. How Do Reproductive Specialists Assess Success Expectations for "Under 35"?

In clinical decision-making, doctors do not rely solely on age but establish an individualized predictive model:

• Step 1: Basic Fertility Assessment — Check sex hormone panel (FSH, LH, E2), AMH, and perform a vaginal ultrasound to measure AFC on days 2‑4 of the menstrual cycle. FSH > 10 IU/L or AMH < 1.5 ng/mL may indicate a diminished ovarian response.
• Step 2: Embryo Potential Prediction — For those with a history of natural conception or previous IVF, embryo quality is often more informative. For first-time IVF patients, doctors will refer to the fertilization rate (normal ≥ 70%) and blastocyst formation rate (normal ≥ 50%).
• Step 3: Uterine Receptivity Screening — Hysteroscopy or sonohysterography is routinely performed before transfer to rule out endometrial polyps, adhesions, or endometritis. For those with recurrent implantation failure, endometrial microbiome or ERA testing may be needed.

Therefore, a woman under 35 with an AMH of 3.5 ng/mL, AFC of 14, and no previous pregnancy history may have an expected pregnancy rate of 60%‑68%; whereas a woman of the same age with an AMH of 0.9 ng/mL, AFC of 5, and a history of chocolate cyst surgery may have an expected pregnancy rate dropping to 40%‑50%.

4. Under 35 vs. 35‑40: How Big is the Success Rate Gap?

Data source: 2022 China Assisted Reproductive Technology Quality Control Report and public data from multiple reproductive centers. It can be seen that under 35 is indeed the optimal fertility window, but "optimal" does not mean "absolute," and individualized assessment remains key.

5. Most Easily Overlooked Details: These 4 Factors Are Often Underestimated by Young Patients

• ① Sperm DNA Fragmentation Index (DFI): Even if the female partner is young, a male DFI > 25% can significantly reduce the fertilization rate and blastocyst formation rate, increasing the risk of miscarriage. Young couples often only focus on the female examination, neglecting the male sperm quality assessment.
• ② Vitamin D Levels: Clinical studies show that serum 25-OH-D < 20 ng/mL is associated with a displaced implantation window and decreased endometrial receptivity. The rate of vitamin D insufficiency in the under-35 population is as high as 40%‑60%, especially among those who work in offices and have limited sun exposure.
• ③ Thyroid Function (TSH): TSH > 2.5 mIU/L, even without reaching clinical hypothyroidism, is associated with decreased implantation rates and increased early miscarriage rates. The incidence of autoimmune thyroiditis (Hashimoto's disease) in young women is about 5%‑8%, and it is often missed.
• ④ Endometrial Peristalsis Wave Frequency: Excessive peristalsis wave frequency (> 3 times/minute) during the implantation window can interfere with embryo positioning, leading to ectopic pregnancy or implantation failure. If the ultrasound doctor does not pay attention to this indicator, it is easily overlooked.

6. Common Cognitive Misconceptions

Myth 1: "Being young means I can choose double embryo transfer to increase success rate"
Double embryo transfer can increase the single-cycle pregnancy rate, but the multiple pregnancy rate can reach 30%‑40%, significantly increasing the risks of preterm birth, preeclampsia, and postpartum hemorrhage. For women under 35 with a normal uterus, the pregnancy rate with single blastocyst transfer can reach 55%‑60%, far superior to the 50% rate with double cleavage-stage embryo transfer, and the multiple pregnancy rate is < 5%.

Myth 2: "High AMH guarantees success"
AMH reflects the quantity of oocytes, not their quality. If a young woman under 35 has AMH > 5 ng/mL with polycystic ovary syndrome (PCOS), she may retrieve many oocytes but have a high proportion of immature oocytes and a high risk of OHSS; the euploidy rate of embryos is not better than that of women with normal AMH.

Myth 3: "Failing the first IVF cycle means my body is incapable"
The incidence of a single failed IVF cycle in the under-35 population is still 30%‑45%, mostly related to random embryonic chromosomal abnormalities or fluctuations in endometrial receptivity, and is not a permanent fertility disorder. The cumulative pregnancy rate (over 2‑3 cycles) can reach 80%‑90%.

7. Key Examination Indicators: How to Interpret Your "Success Potential"

The above indicators need to be interpreted comprehensively by a reproductive specialist. A single abnormal indicator does not mean absolute failure, but if multiple indicators are abnormal, they should be addressed before starting a cycle.

8. Frequently Asked Questions

Q1: Do women under 35 need PGT-A for IVF?
Without clear indications (such as recurrent miscarriage, chromosomal structural abnormalities, or severe male factor), PGT-A offers limited improvement in live birth rates for the under-35 population and carries risks of embryo biopsy damage, increased costs, and a reduction in the number of available embryos. The current mainstream view is that for young women without clear genetic risks, morphological grading combined with blastocyst culture is preferred over routine PGT-A.

Q2: What is the success rate for the first IVF cycle? If it fails, will the second cycle have a higher success rate?
The clinical pregnancy rate for the first IVF cycle in women under 35 is approximately 50%‑60%. If the first cycle fails, the doctor will analyze the reasons (embryo factors, endometrial factors, protocol issues) and make targeted adjustments. The pregnancy rate for the second cycle is usually comparable to or slightly higher than the first, and the cumulative pregnancy rate can reach over 80%.

Q3: How long should I prepare before egg retrieval? What should I eat?
Start lifestyle adjustments at least 2‑3 months in advance: protein intake of 1.2‑1.5 g/kg body weight, supplementation with Coenzyme Q10 (200‑300 mg/day), Vitamin D3 (1000‑2000 IU/day), and folic acid 400 μg/day. The male partner should also supplement with zinc, selenium, and L-carnitine. However, it is important to note that nutritional supplements cannot replace medical intervention and have limited effect in those with severely diminished ovarian reserve.

Q4: I'm young but have low AMH. Should I go directly for IVF or try to conceive naturally first?
If AMH is < 1.1 ng/mL and you have been trying to conceive for more than 6 months without success, it is recommended to proceed directly to IVF evaluation rather than continuing to wait. This is because the decline in ovarian reserve is progressive, and the time window is limited. At the same time, perform a semen analysis for the male partner and a hysterosalpingography for the female partner to rule out other factors.

9. Observations from Practitioners: Psychological and Decision-Making Factors Most Easily Overlooked by Young Patients

In clinical practice, a common characteristic of patients under 35 is that they have excessively high expectations for "success on the first try" and insufficient psychological preparation for "failure". After a failed first transfer, some patients fall into self-doubt and may even hastily switch reproductive centers or doctors, leading to discontinuous cycles and repeated tests, which ultimately delays time.

My advice is to establish a rational expectation framework before starting a cycle — a single-cycle pregnancy rate of 50%‑65% means that one in three young women may need two or more transfers. This is not a sign that the body is "incapable," but rather the natural probability of the reproductive process. Working with your doctor to create a "Plan A plus backup options" (such as a frozen embryo transfer strategy after a failed fresh transfer, blastocyst culture strategy, or ERA testing timing) can significantly reduce decision-making anxiety.

Author: Clinical Physician at Reproductive Medicine Center ｜ Knowledge Base Version: v2.4 (Updated March 2025)
This article is intended solely as a科普 of assisted reproductive technology and does not constitute medical advice. Data is sourced from publicly available quality control reports and clinical consensus.